A medical device company that was founded to solve an unsafe and complicated problem of filtering. CarrTech has built and patented and submitted to the FDA the first and only integrated all in one package, one- needle, one-step filter pioneering a safer, more efficient, and cost-effective way to preparing ampoule-based medications.
Reaching for the “holy grail” of oral biologics with a first-in-class modality intended for gastrointestinal (GI)-related diseases including gut-health axis disorders.
i-Lumen Scientific™ is a retinal biotech company, pioneering a new field in ophthalmics, designed to improve eyesight in patients whose vision has been impaired by nonexudative (dry) age-related macular degeneration (dAMD).
Natáur's fermentation-based platform provides a cost-competitive, environmentally friendly alternative to the traditional petroleum supply chain for sulfur ingredients.
NeuroEM's first-of-its-kind device offers a safe, effective, and non-invasive approach to treating neurodegenerative diseases, including Alzheimer's, and protecting brain health throughout the aging process.
At Novel Microdevices, we are revolutionizing diagnostics with our Next-Gen, Patent-Protected Point-of-Care PCR Platform, delivering lab accuracy, rapid results, and unmatched affordability.
PredxBio is powering next-generation cancer therapeutics with AI-driven spatial biomarkers that delves into the mechanism of action of drugs and predicts the patient outcomes with over 90% accuracy.
Tympanogen develops ear, nose, and throat (ENT) devices that simplify existing
procedures and improve treatment outcomes using our proprietary gel technology.
